|
Immunobiology
Citations 231-240 of 4005 total displayed.
|
Past content
(since Jan 1997):
|
T-cell receptor– and CD28-induced Vav1 activity is required for the accumulation of primed T cells into antigenic tissue
- Rachel David, Liang Ma, Aleksandar Ivetic, Aya Takesono, Anne J. Ridley, Jian-Guo Chai, Victor L. Tybulewicz, and Federica M. Marelli-Berg
Blood 2009; 113: 3696-3705.
[Abstract]
[Full text]
[PDF]
Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting
- Nancy S. Longo, Patricia L. Lugar, Sule Yavuz, Wen Zhang, Peter H. L. Krijger, Daniel E. Russ, Dereje D. Jima, Sandeep S. Dave, Amrie C. Grammer, and Peter E. Lipsky
Blood 2009; 113: 3706-3715.
[Abstract]
[Full text]
[PDF]
Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- Pierre Bruhns, Bruno Iannascoli, Patrick England, David A. Mancardi, Nadine Fernandez, Sylvie Jorieux, and Marc Daëron
Blood 2009; 113: 3716-3725.
[Abstract]
[Full text]
[PDF]
In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein
- Risaku Fukumoto, Vibeke Andresen, Izabela Bialuk, Valentina Cecchinato, Jean-Claude Walser, Valerio W. Valeri, Julie M. Nauroth, Antoine Gessain, Christophe Nicot, and Genoveffa Franchini
Blood 2009; 113: 3726-3734.
[Abstract]
[Full text]
[PDF]
Differentiation stage–specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas
- Raquel Malumbres, Kristopher A. Sarosiek, Elena Cubedo, Jose W. Ruiz, Xiaoyu Jiang, Randy D. Gascoyne, Robert Tibshirani, and Izidore S. Lossos
Blood 2009; 113: 3754-3764.
[Abstract]
[Full text]
[PDF]
Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20
- David Daydé, David Ternant, Marc Ohresser, Stéphanie Lerondel, Sabrina Pesnel, Hervé Watier, Alain Le Pape, Pierre Bardos, Gilles Paintaud, and Guillaume Cartron
Blood 2009; 113: 3765-3772.
[Abstract]
[Full text]
[PDF]
A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity
- John E. Weldon, Laiman Xiang, Oleg Chertov, Inger Margulies, Robert J. Kreitman, David J. FitzGerald, and Ira Pastan
Blood 2009; 113: 3792-3800.
[Abstract]
[Full text]
[PDF]
Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab
- Shannon P. Hilchey, Ollivier Hyrien, Tim R. Mosmann, Alexandra M. Livingstone, Jonathan W. Friedberg, Faith Young, Richard I. Fisher, Raymond J. Kelleher, Jr, Richard B. Bankert, and Steven H. Bernstein
Blood 2009; 113: 3809-3812.
[Abstract]
[Full text]
[PDF]
Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation
- Masafumi Nakayama, Hisaya Akiba, Kazuyoshi Takeda, Yuko Kojima, Masaaki Hashiguchi, Miyuki Azuma, Hideo Yagita, and Ko Okumura
Blood 2009; 113: 3821-3830.
[Abstract]
[Full text]
[PDF]
T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a–specific, HLA-DRB3*0101–restricted CD4+ T cells
- Maria Therese Ahlen, Anne Husebekk, Mette Kjær Killie, Bjørn Skogen, and Tor B. Stuge
Blood 2009; 113: 3838-3844.
[Abstract]
[Full text]
[PDF]
|
|
